Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphoma.
Leon D KaulenChristoph GumbingerFelix HinzTobias KesslerFrank WinklerMartin BendszusFelix SahmWolfgang WickPublished in: Neuro-oncology advances (2022)